Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06126107 · ClinicalTrials.gov registry record · NA
Gain and Loss Framed Text Messaging to Reduce Drinking Among Older Adults
A NA study of Alcohol Consumption, sponsored by Hunter College of City University of New York.
- Completed
- Registry status
- NA
- Development phase
- 133
- Enrollment target
- 1
- Study location
NCT06126107: Completed NA study of Alcohol Consumption, sponsored by Hunter College of City University of New York.
NCT06126107 is a NA study of Alcohol Consumption that has completed, run by Hunter College of City University of New York. The registered enrollment target is 133 participants, below the 368-participant average among 18 other Alcohol Consumption trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06126107, a NA study of Alcohol Consumption, has completed, sponsored by Hunter College of City University of New York.
- COMPLETED
- Registry status
- NA
- Development phase
- 133 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to evaluate effectiveness of scalable, tailored text- messaging programs for alcohol use among older adults. This study focuses on gain and loss framing of behavior change goals (i.e., the positives of change and the negatives of remaining with the status quo), critical components of behavioral science and health behavioral interventions. Loss-framing is used to motivate individuals to avoid future problems by focusing on the consequences of no change in behavior, and gain-framing is used to facilitate progress by focusing on the benefits of change. The investigators will design and evaluate three text-messaging programs using a randomized controlled trial: (A) Loss-framed messaging (B) Gain-framed messaging; and (C) Combined (loss and gain) messaging among a sample of 150 older adults with hazardous drinking. Participants will be randomized to one of the three conditions, each of which will include 8 weeks of text-messaging. During the study participants will completed assessments online and via text messages to track drinking.
Primary Outcome
Measure 1 of drinking, average of weekly sum of standard drinks
Conditions Studied
Interventions
- BEHAVIORAL Brief Normative Feedback
- BEHAVIORAL Loss-framed Text-messaging
- BEHAVIORAL Gain-framed Text-messaging
Study Locations (1)
New York
- Hunter College of CUNY - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 133 participants |
| Start Date | 2024-02-26 |
| Est. Completion | 2024-12-10 |
| Phase | NA |
What the finished NCT06126107 record still lists
NCT06126107 is an interventional study that assigns participants to a tested intervention. The registered 133 participants enrollment target is mid-sized for trials with a published cap, below the 368-participant average among 18 other Alcohol Consumption trials with a reported enrollment target (64% lower).
The record links to 1 condition, with Alcohol Consumption appearing as the primary indexed condition, and to 3 interventions - of which Brief Normative Feedback is the first listed.
NCT06126107 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT06126107 about?
NCT06126107 is a clinical study titled "Gain and Loss Framed Text Messaging to Reduce Drinking Among Older Adults". The goal of this study is to evaluate effectiveness of scalable, tailored text- messaging programs for alcohol use among older adults. This study focuses on gain and loss framing of behavior change goals (i.e., the positives of change and the negatives of remaining with the status quo), critical com...
What is the current status of trial NCT06126107?
This trial is currently completed. It is a NA study. The enrollment target is 133 participants. The study started on 2024-02-26. Estimated completion is 2024-12-10.
What conditions does trial NCT06126107 study?
This clinical trial studies the following conditions: Alcohol Consumption.
What interventions are being tested in trial NCT06126107?
The interventions under investigation include: Brief Normative Feedback (BEHAVIORAL), Loss-framed Text-messaging (BEHAVIORAL), Gain-framed Text-messaging (BEHAVIORAL).
Who is sponsoring clinical trial NCT06126107?
This trial is sponsored by Hunter College of City University of New York, which has 29 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06126107 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alcohol Consumption
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06126107's enrollment target sits among peer trials
133 10th of 18 higher than 9 of 18 other Alcohol Consumption trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Alcohol Consumption trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Phosphatidylethanol and Other Ethanol Consumption Markers
RECRUITING · NA
-
Accountability Support Through Peer-Inspired Relationships and Engagement (ASPIRE) Trial
RECRUITING · NA
-
Social Facilitation of Alcohol Effects and Alcohol Misuse in Young Adults
RECRUITING · NA
-
Transcranial Magnetic Stimulation (TMS) Effects Using Magnetoencephalography (MEG) Study
RECRUITING · NA
-
Drinking in Young Adult Duos (DYAD) Study
RECRUITING · NA
-
Engineering an Online STI Prevention Program: RCT
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04276870 · 133 participants · Phase 2
Orphan Indications for CD19 Redirected Autologous T Cells
- NCT04671771 · 133 participants · NA
A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
- NCT05610085 · 133 participants · Phase 2
A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures
- NCT06206486 · 133 participants
The Gut Microbiome and Serum Metabolites As a Biological Mechanism Underlying Pain in Kidney Transplantation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI